BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21819342)

  • 1. The impact of severe hyperemesis gravidarum on the triple test screening results.
    Peled Y; Melamed N; Krissi H; Eitan R; Yogev Y; Pardo J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):637-8. PubMed ID: 21819342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are thyroid hormones or hCG responsible for hyperemesis gravidarum? A matched paired study in pregnant Chinese women.
    Panesar NS; Li CY; Rogers MS
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):519-24. PubMed ID: 11380287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum screening for birth defects: results of a Connecticut regional program.
    Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
    Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum triple analyte screening in pregnancy.
    Graves JC; Miller KE; Sellers AD
    Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does low molecular weight heparin influence the triple test result in pregnant women with thrombophilia?
    Wiener Y; Frank M; Neeman O; Kurzweil Y; Bar J; Maymon R
    Isr Med Assoc J; 2012 Apr; 14(4):247-50. PubMed ID: 22675844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
    Heyl PS; Miller W; Canick JA
    Obstet Gynecol; 1990 Dec; 76(6):1025-31. PubMed ID: 1700348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Down's screening test associated with severe hyperemesis gravidarum.
    Pradhan P; Mohajer M
    J Obstet Gynaecol; 2002 Nov; 22(6):692. PubMed ID: 12554274
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A; Akkawi M
    East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome in hyperemesis gravidarum and the effect of laboratory clinical indicators of hyperemesis severity.
    Tan PC; Jacob R; Quek KF; Omar SZ
    J Obstet Gynaecol Res; 2007 Aug; 33(4):457-64. PubMed ID: 17688612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
    Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
    Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone profile of Kuwaiti women with hyperemesis gravidarum.
    Al-Yatama M; Diejomaoh M; Nandakumaran M; Monem RA; Omu AE; Al Kandari F
    Arch Gynecol Obstet; 2002 Aug; 266(4):218-22. PubMed ID: 12192483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal human chorionic gonadotrophin concentrations in very early pregnancy and risk of hyperemesis gravidarum: A retrospective cohort study of 4372 pregnancies after in vitro fertilization.
    Dypvik J; Pereira AL; Tanbo TG; Eskild A
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():12-16. PubMed ID: 29227846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis using the triple test.
    Palka G; Guanciali Franchi P; Papponetti M; Marcuccitti J; Morizio E; Calabrese G; Stuppia L; Di Ilio C
    Minerva Ginecol; 1998 Oct; 50(10):411-5. PubMed ID: 9866951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.